Impinj (PI) Q1 2026 Earnings Transcript

Impinj reported flat year-over-year revenue of $74.3 million and record endpoint IC bookings, with endpoint IC revenue up 3% year over year despite weaker systems revenue and a 20% sequential decline in total sales. Management guided Q2 revenue to $103 million-$106 million and adjusted EBITDA to $27.8 million-$29.3 million, while gross margin is expected to improve sequentially as a one-time production issue is resolved and M800 ramps continue. The company also repurchased $40.2 million of convertible notes, reducing potential dilution by roughly 400,000 shares.

Analysis

The key signal is not the headline top-line miss; it is the combination of record bookings, a clean-looking channel reset, and management’s willingness to pre-announce a stronger Q2 gross margin profile even while staying cautious on H2. That tells us the operating leverage in PI is still very real: when utilization normalizes and channel inventory is lean, incremental endpoint demand should drop through with outsized margin expansion. The market is likely underappreciating how much of the near-term earnings power is being capped by transitory production friction rather than demand quality.

The competitive read-through is more interesting. PI appears to be using a “land with hardware, expand with software + enterprise workflows” playbook that raises switching costs and reduces the relevance of pure tag/IC comparisons. If that enterprise motion works, the real loser is not just NXP; it is any competitor relying on channel fill rather than embedded workflow integration, because PI can monetize both read-performance improvements and the data layer around them. The royalty stream adds a second-order lever: even if the new competitor chip eventually redesigns around IP, the interim royalty cash is helping finance buybacks and dilution reduction, which tightens per-share upside.

The main risk is timing, not thesis. Near-term upside can continue for 1-2 quarters if retail rebuys and logistics conversion hold, but H2 is exposed to any macro-driven destocking reversal; that would hit systems first, then endpoint volumes, then margin. The market is also likely extrapolating too much from one quarter of record bookings—bookings were helped by lead-time normalization and competitor lead-time issues, which may not be durable. In other words, the stock can work if execution stays clean, but the path is likely choppy because the valuation now has to discount both cyclical recovery and platform optionality simultaneously.

Key Decisions for Investors

• Go long PI on pullbacks over the next 1-3 weeks, using the post-earnings digestion period as entry; risk/reward favors a 2:1 setup if Q2 confirms sequential gross margin expansion and bookings remain elevated.
• Pair trade: long PI / short NXP over the next 1-2 quarters; PI has the cleaner operating leverage and IP/royalty optionality, while NXP carries direct competitive and redesign risk with less visible upside.
• Buy PI call spreads out 3-6 months to express upside from margin normalization without paying full-premium for H2 macro risk; target strikes that monetize a rerating if Q2 and Q3 both confirm demand acceleration.
• Trim or hedge PI into any sharp post-earnings rally above near-term implied earnings power; the asymmetric risk is that H2 macro uncertainty can compress multiples quickly if retail rebuys slow.
• Watch for a tactical long in AVY on any pullback only if it benefits from broader RFID adoption without PI-specific margin risk; otherwise PI is the cleaner direct expression of the theme.